213 related articles for article (PubMed ID: 24919980)
1. Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
Leissinger C; Josephson CD; Granger S; Konkle BA; Kruse-Jarres R; Ragni MV; Journeycake JM; Valentino L; Key NS; Gill JC; McCrae KR; Neufeld EJ; Manno C; Raffini L; Saxena K; Torres M; Marder V; Bennett CM; Assmann SF
Thromb Haemost; 2014 Sep; 112(3):445-58. PubMed ID: 24919980
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.
Biswas M; Rogers GL; Sherman A; Byrne BJ; Markusic DM; Jiang H; Herzog RW
Thromb Haemost; 2017 Jan; 117(1):33-43. PubMed ID: 27683758
[TBL] [Abstract][Full Text] [Related]
4. Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre.
Chuansumrit A; Husapadol S; Wongwerawattanakoon P; Hongeng S; Sirachainan N; Pakakasama S
Haemophilia; 2007 Jan; 13(1):108-10. PubMed ID: 17212736
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor treatment by rituximab in congenital haemophilia A - Two case reports.
Streif W; Escuriola Ettingshausen C; Linde R; Kropshofer G; Zimmerhackl LB; Kreuz W
Hamostaseologie; 2009 May; 29(2):151-4. PubMed ID: 19404522
[TBL] [Abstract][Full Text] [Related]
6. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP
Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor development and management in three non-severe haemophilia A patients with T295A variant.
Ivaskevicius V; Goldmann G; Horneff S; Marquardt N; Klein C; Albert T; Zeitler H; Oldenburg J
Hamostaseologie; 2014; 34 Suppl 1():S9-12. PubMed ID: 25382774
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience.
Carcao M; St Louis J; Poon MC; Grunebaum E; Lacroix S; Stain AM; Blanchette VS; Rivard GE;
Haemophilia; 2006 Jan; 12(1):7-18. PubMed ID: 16409170
[TBL] [Abstract][Full Text] [Related]
9. Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.
Nakar C; Manco-Johnson MJ; Lail A; Donfield S; Maahs J; Chong Y; Blades T; Shapiro A
Haemophilia; 2015 May; 21(3):365-373. PubMed ID: 25581638
[TBL] [Abstract][Full Text] [Related]
10. Rituximab as first-line treatment for the management of adult patients with non-severe hemophilia A and inhibitors.
Lim MY; Nielsen B; Lee K; Kasthuri RS; Key NS; Ma AD
J Thromb Haemost; 2014 Jun; 12(6):897-901. PubMed ID: 24702722
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.
Mancuso ME; Fischer K; Santagostino E; Oldenburg J; Platokouki H; Königs C; Escuriola-Ettingshausen C; Rivard GE; Cid AR; Carcao M; Ljung R; Petrini P; Altisent C; Kenet G; Liesner R; Kurnik K; Auerswald G; Chambost H; Mäkipernaa A; Molinari AC; Williams M; van den Berg HM;
Thromb Haemost; 2017 Dec; 117(12):2274-2282. PubMed ID: 29212115
[TBL] [Abstract][Full Text] [Related]
12. Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.
Unuvar A; Warrier I; Lusher JM
Haemophilia; 2000 May; 6(3):150-7. PubMed ID: 10792472
[TBL] [Abstract][Full Text] [Related]
13. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
Kreuz W; Escuriola Ettingshausen C; Vdovin V; Zozulya N; Plyushch O; Svirin P; Andreeva T; Bubanská E; Campos M; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Klukowska A; Momot A; Osmulskaya N; Prieto M; Šalek SZ; Velasco F; Pavlova A; Oldenburg J; Knaub S; Jansen M; Belyanskaya L; Walter O; ;
Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in the treatment of high responding inhibitors in severe haemophilia A.
Moschovi M; Aronis S; Trimis G; Platokouki H; Salavoura K; Tzortzatou-Stathopoulou F
Haemophilia; 2006 Jan; 12(1):95-9. PubMed ID: 16409183
[TBL] [Abstract][Full Text] [Related]
15. Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature.
Biss TT; Velangi MR; Hanley JP
Haemophilia; 2006 May; 12(3):280-4. PubMed ID: 16643214
[TBL] [Abstract][Full Text] [Related]
16. [Long-term response to rituximab in a patient with acquired hemophilia].
García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
[TBL] [Abstract][Full Text] [Related]
17. Low-dose rituximab in the treatment of acquired haemophilia.
Yao Q; Zhu X; Liu Y; Zhang F; Yuan T; Xu J; Wang X
Hematology; 2014 Dec; 19(8):483-6. PubMed ID: 24611711
[TBL] [Abstract][Full Text] [Related]
18. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for autoimmune haemophilia: a proposed treatment algorithm.
Aggarwal A; Grewal R; Green RJ; Boggio L; Green D; Weksler BB; Wiestner A; Schechter GP
Haemophilia; 2005 Jan; 11(1):13-9. PubMed ID: 15660983
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in the treatment of acquired factor VIII inhibitors.
Wiestner A; Cho HJ; Asch AS; Michelis MA; Zeller JA; Peerschke EI; Weksler BB; Schechter GP
Blood; 2002 Nov; 100(9):3426-8. PubMed ID: 12384448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
